Arcus Biosciences Inc (NYSE:RCUS)
| 17.99 BATS BZX Real-Time Price As of 2:37pm ET |  -0.07 / -0.39%Today’s Change | 15.70 Today|||52-Week Range 36.13 | -13.01% Year-to-Date |
Latest RCUS News | Press Releases
| Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength? Sep 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 18.06 |
| Today’s open | 18.48 |
| Day’s range | 17.63 - 18.48 |
| Volume | 355,542 |
| Average volume (3 months) | 1,007,815 |
| Market cap | $1.5B |
Data as of 2:37pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -586.78% |
| Earnings growth (this year) | -21.94% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -70.75% |
| P/E ratio | NM |
| Price/Sales | 13.29 |
| Price/Book | 2.19 |
Competitors
| ---- | ||
| BCRXBioCryst Pharmaceuti... | -0.17 | -2.42% |
| RYTMRhythm Pharmaceutica... | -0.37 | -1.60% |
| MRUSMerus NV | -1.36 | -5.55% |
Data as of 2:37pm ET, 09/29/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | -$1.17 |
| Annual revenue (last year) | $112.0M |
| Annual profit (last year) | -$267.0M |
| Net profit margin | -238.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Hayward, California |
Forecasts
